Skip to content ↓

Cambridge First Day honors six

Press Contact:

Sarah Gallop
Phone: 617-253-0942
MIT Office of Government and Community Relations
Close

The 14th annual Cambridge First Day at MIT will honor six Cambridge institutions for "Bridging the Digital Divide" in the city.

Awards will be presented on Tuesday, June 13, to Cambridge Housing Authority's Community Computer Centers; Community Learning Center: Project LIFT; Margaret Fuller Neighborhood House's Computer Tech Center; East End House's Technology Center; Cambridge Community Television: ComputerCENTRAL; and MIT CommuniTech.

Each will receive a framed Cambridge First Day Award, $1,000 to help continue their work and a bound City Council resolution.

The program begins at 11 a.m. in the Mezzanine Lounge of the Stratton Student Center and will be followed by an informal buffet luncheon. Speakers will include Cambridge Mayor Kenneth E. Reeves, MIT Executive Vice President Sherwin Greenblatt and Cambridge City Manager Robert W. Healy.

Established in 1993, Cambridge First Day provides an opportunity for MIT to express its appreciation to the Cambridge community for the vital partnerships that exist among MIT and local businesses, public officials and residents of Cambridge.

Jointly planned and hosted by MIT and the city since 1997, Cambridge First Day focuses on a different theme each year.

A version of this article appeared in MIT Tech Talk on June 7, 2006 (download PDF).

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story